JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues

Inflammation Research

Volumn 49, Issue 3, 2000, Pages 117-122

  Wakitani, K ^a   Tazaki, H ^a   Matsushita, M ^a   Iwamura, H ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

Cyclooxygenase 2; JTE 522; Prostaglandin; Thromboxane; Western blot

Indexed keywords

CALCIMYCIN; CARRAGEENAN; CYCLOOXYGENASE 2; INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN E2; THROMBOXANE B2; TILMACOXIB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; INFLAMMATION; MALE; NONHUMAN; PAW EDEMA; PERITONEUM MACROPHAGE; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; STOMACH MUCOSA;

EID: 0034033199     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050568     Document Type: Article

References (27)

1. [1] Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Ann Rev Biochem 1986; 55: 69-102.
2. [2] Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Ann Rev Immunol 1984; 2: 335-57.
3. [3] Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232-5.
4. [4] Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991; 88: 2692-6.
5. [5] DeWitt DL, Smith WL. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 1988; 85: 1412-6.
6. [6] DeWitt DL, El-Harith EA, Kraemer SA, Andrews MJ, Yao EF, Armstrong RL, et al. The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. J Biol Chem 1990; 265: 5192-8.
7. [7] Yokoyama C, Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun 1989; 165: 888-94.
8. [8] Xie W, Robertson DL, Simmons DL. Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs. Drug Devel Res 1992; 25: 249-65.
9. [9] Smith WL, Marnett LJ. Prostaglandin endoperoxide synthases. Metal Ions Biol Syst 1994; 30: 163-99.
10. [10] Kennedy BP, Chan CC, Culp SA, Cromlish WA. Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA. Biochem Biophys Res Commun 1993; 197: 494-500.
11. [11] Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994; 91: 3228-32.
12. [12] Harada Y, Hatanaka K, Saito M, Majima M, Ogino M, Kawamura M, et al. Detection of inducible prostaglandin H synthase-2 in cells in the exudate of rat carrageenin-induced pleurisy. Biomed Res 1994; 15: 127-30.
13. [13] Wakitani K, Nanayama T, Masaki M, Matsushita M. Profile of JTE-522 as a human cyclooxygenase-2 inhibitor. Jpn J Pharmacol 1998; 78: 365-71.
14. [14] Matsushita M, Masaki M, Yagi Y, Tanaka T, Wakitani K. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats. Inflamm Res 1997; 46: 461-6.
15. [15] Masaki M, Matsushita M, Wakitani K. Inhibitory effects of JTE-522, a novel prostaglandin H synthase-2 inhibitor, on adjuvant-induced arthritis and bone changes in rats. Inflamm Res 1998; 47: 187-92.
16. [16] Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-10.
17. 2 production. J Pharmacol Exp Ther 1997; 283: 1069-75.
18. [18] Brideau C, Kargman S, Liu S, Dallob AL, Ehrich EW, Rodger IW et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res 1996; 45: 68-74.
19. 2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages. J Pharmacol Exp Ther 1997; 281: 1005-12.
20. [20] Habib A, Bernard C, Lebret M, Creminon C, Esposito B, Tedgui A, Maclouf J. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages. J Immunol 1997; 158: 3845-51.
21. [21] Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Pro Soc Exp Bio Med 1962; 111: 544-50.
22. [22] Otterness IG, Bliven ML. Laboratory models for testing nonsteroidal anti-inflammatory drugs. In: Lombardino JG, editor. Nonsteroidal antiinflammatory drugs. New York: Wiley, 1985: 116-128.
23. [23] Futaki N, Yoshikawa K, Hamasaka Y, Arai I, Higuchi S, Iizuka H, et al. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmacol 1993; 24: 105-10.
24. [24] Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994; 91: 12013-17.
25. [25] Pang L, Hoult JRS. Induction of cyclooxygenase and nitric oxide synthase in endotoxin-activated J774 macrophages is differentially regulated by indomethacin: Enhanced cyclooxygenase-2 protein expression but reduction of inducible nitric oxide synthase. Eur J Pharmacol 1996; 317: 151-5.
26. [26] Callejas NA, Castrillo A, Bosca L, Martin-Sanz P. Inhibition of prostaglandin synthesis up-regulates cyclooxygenase-2 induced by lipopolysaccharide and peroxisomal proliferators. J Pharmacol Exp Ther 1999; 288: 1235-41.
27. [27] Pang L, Heras B, Hoult JRS. A novel diterpenoid labdane from Sideritis javalambresis inhibits eicosanoid generation from stimulated macrophages but enhances arachidonate release. Biochem Pharmacol 1996; 51: 863-8.